Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
🌐 ES Home Catalog Education COAs Calculator Founder
Cerebrolysin
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Cognitive & Sleep › Cerebrolysin
← Back to catalog Cognitive & SleepAvailable

Cerebrolysin (60 mg)

NeuroprotectorApprovedRecovery
$89 USD
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Mix of porcine brain-derived neuropeptides — neuroprotector approved in 50+ countries for Alzheimer's, stroke, and dementia.

  • Mechanism: Mix of porcine brain-derived neuropeptides with neurotrophic action.
  • Evidence: Extensive clinical use outside the US (stroke, dementia, TBI); Western meta-analyses debate efficacy.
  • In context: Approved in 50+ countries. Animal-derived biologic (variability).
Rango de investigación · SC
Not administered SC
🟢 Clinical evidence · IV/IM only; manufacturer says never SC

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundCerebrolysin
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaAvailable on request
Molecular weightAvailable on request
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

Cerebrolysin: research profile

Cerebrolysin is not a single peptide but a standardized mixture of low-molecular-weight peptides (under 10 kDa) and free amino acids obtained by controlled enzymatic digestion of porcine brain proteins. Ever Pharma (Austria) has produced it since the 1950s, and it is a biological product: its composition is defined by the manufacturing process rather than a chemical formula, so it has no single sequence or molecular mass. Renova's vial contains 60 mg of the lyophilized peptide fraction.

The working hypothesis is that the mixture mimics endogenous neurotrophic factors such as BDNF, NGF and CNTF: in neuronal cultures and in animal models of ischemia, trauma and neurodegeneration it reduces apoptosis, modulates calpain and GSK-3β signaling, favors neurogenesis and synaptogenesis and attenuates the inflammatory response. Being a mixture, attributing each effect to a specific component is difficult, which complicates its pharmacological characterization.

It is authorized in some fifty countries — Russia, China, Austria, South Korea, much of Eastern Europe and Latin America — for stroke, traumatic brain injury and dementias, always by the intravenous or intramuscular route; the product label specifies it must not be given subcutaneously. Cochrane reviews on acute stroke and vascular dementia judge the evidence of benefit uncertain or low-quality. It holds no FDA approval and no centralized EMA approval. Renova distributes it for research only.

Cerebrolysin technical data

ClassPorcine-derived neurotrophic peptide mixture (biological product)
CompositionPeptides < 10 kDa (≈ 25%) and free amino acids (≈ 75%) from porcine brain; no single sequence
Reference producerEver Pharma (Austria), since the 1950s
Proposed mechanismsBDNF/NGF/CNTF mimicry; ↓ apoptosis (calpain, GSK-3β); neurogenesis; anti-inflammatory
Clinical routesIntravenous or intramuscular; the product label excludes the subcutaneous route
Regulatory statusAuthorized in ≈ 50 countries; no FDA approval; Cochrane reviews: uncertain evidence
NoteAnimal origin: lot-to-lot variability and biological-product considerations
Renova presentation60 mg lyophilized fraction; research only

Questions about Cerebrolysin

Is Cerebrolysin a peptide?

Not exactly: it is a mixture of many small peptides and amino acids obtained from pig brain proteins. That is why it has no single sequence or molecular weight, and its identity is defined by the manufacturing process. In that sense it resembles a standardized extract more than a synthetic compound.

In which countries is Cerebrolysin approved?

In around fifty: Russia, China, Austria, South Korea and much of Eastern Europe and Latin America, for stroke, head trauma and dementias, by the intravenous or intramuscular route. It has no FDA approval. Renova's product is research material, not the registered medicine.

What do independent reviews say about Cerebrolysin?

Cochrane reviews on acute ischemic stroke and vascular dementia conclude that the evidence of benefit is uncertain or low-quality, with heterogeneity between trials and risk of bias. Meta-analyses by authors linked to Ever Pharma are more favorable. It is a case where the breadth of clinical use exceeds the strength of the evidence.

Why does the Cerebrolysin label exclude the subcutaneous route?

Because all clinical experience and safety studies correspond to the intravenous and intramuscular routes, and the product label expressly excludes the subcutaneous one. In research that restriction is a relevant input for experimental design.

Related reading: Cerebrolysin: Neurotrophic Peptide Blend · Semax and Selank: The Russian Peptide Nootropics

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty